Johnson says no moratorium on AI, would give China competitive edge
At a glance
- $JNJ today−1.89%last $277.20
- Since Sep 15+3.71%from the first trade after the story
- 52-week range4.5% below high$198.53 – $290.25
- Coverage0 this week11 in 30 days · quieter than usual
- Next upIn 70 days$JNJ earnings
- Sector scannerCalmHealth Care
Nothing reported about Johnson & Johnson across key-person, legal, regulatory, security, operational or financial-integrity risk in three weeks of coverage and 30 days of SEC filings.
Ranges are one standard deviation of volatility around the latest close — about 1 week in 3 moves further. Not a forecast or investment advice.
What it means
- What to watch: In healthcare, the calendar is the catalyst: trial readouts, FDA dates and pricing rules drive most of the moves.
- How the stock is trading: $JNJ -1.89% in the latest session.
- Timing: It was published while New York was trading, so the day's move may already include the first reaction.
Where the stock stands
Johnson & Johnson ($JNJ) declined 1.89% to $277.20 in the latest session. Over the past month it is up 9.8%. It now sits 4.5% under the 52-week high of $290.25 and 40% above the year's low of $198.53. The high sits 46% above the low, a moderate range for a year.
How much coverage it is getting
This story is more than a month old. Since then Wook has filed 11 newer stories on Johnson & Johnson in the last 30 days, 0 of them this week. By their wording, 18% read bullish, 55% neutral and 27% bearish.
The bigger picture
In healthcare, the calendar is the catalyst — trial readouts, FDA decisions and pricing rules. One result can move a single drugmaker sharply; a policy change moves the whole aisle. Health Care reads calm on Wook's supply-chain scanner today, with no unusual stress in the filings and disclosures it watches.
Coming up
$JNJ earnings in 70 days, a date set before this story ran.
What to watch next
The company's own filings are the primary source. Its latest SEC reports, including any filing on a material event, are on the $JNJ page, and they say what management has disclosed without a reporter in between. Where several outlets agree is usually the news; where they differ is the angle. Wook AI, at the top of the page, can work out how far $JNJ is from its high or compare this week's coverage with earlier weeks.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Investing.com published this on September 15, 2026. $JNJ has moved +3.71% ($267.28 to $277.20). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.
